Chlamydia


Autoria(s): Hafner, Louise M.; Timms, Peter
Contribuinte(s)

Stanberry, Lawrence R.

Rosenthal, Susan L.

Data(s)

01/01/2013

Resumo

Chlamydial infections of humans can cause blindness and infertility as a result of diseases such as keratoconjunctivitis (trachoma), urethritis and cervicitis. However, in greater than half of all chlamydial diseases in males and females there are no signs or symptoms of infection. Chlamydia trachomatis is the causative bacterial organism responsible for the global estimate of 40.6 million people currently suffering with active trachoma and for the five million new cases of sexually transmitted infections each year in the United States of America. Even though antibiotics are available to treat Chlamydia, the incidence of each of these primarily asymptomatic infections continues to increase. In this Chapter we review the current knowledge of C.trachomatis including clinicial diseases and sequelae, the chlamydial developmental cycle in vivo, immunobiology and immune responses to infections, chlamydial genomics and vaccine development.

Formato

application/pdf

Identificador

http://eprints.qut.edu.au/47925/

Publicador

Elsevier

Relação

http://eprints.qut.edu.au/47925/1/47925.pdf

DOI:10.1016/B978-0-12-391059-2.00015-2

Hafner, Louise M. & Timms, Peter (2013) Chlamydia. In Stanberry, Lawrence R. & Rosenthal, Susan L. (Eds.) Sexually Transmitted Diseases : Vaccines, Prevention, and Control (Second Edition). Elsevier, Waltham, Mass, pp. 369-410.

Direitos

Copyright 2013 Elsevier Ltd.

Fonte

Cell & Molecular Biosciences; Faculty of Health; Institute of Health and Biomedical Innovation

Palavras-Chave #060502 Infectious Agents #Chlamydia trachomatis #Vaccine Development
Tipo

Book Chapter